SCHEMBL5086159

SCHEMBL5086159

Cc1cc(-c2ccccn2)nc2cc(Nc3nccn4c(C5CCC5)ncc34)ccc12

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TNK2 Q07912 5/20 0.35
SYK P43405 1/20 0.35
ALDH1A1 P00352 3/20 0.34
KDM4E B2RXH2 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
LMNA P02545 2/20 0.34
HPGD P15428 1/20 0.34
HSD17B10 Q99714 1/20 0.34
TGFBR1 P36897 1/20 0.33
CYP3A4 P08684 2/20 0.33
PDE10A Q9Y233 2/20 0.33
IGF1R P08069 1/20 0.33
ADORA3 P0DMS8 1/20 0.33
ABCB1 P08183 1/20 0.33
ABCG2 Q9UNQ0 1/20 0.33
METAP1 P53582 1/20 0.32
GAA P10253 1/20 0.32
HTT P42858 1/20 0.32
GFER P55789 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5082928 0.90 IGF1R (0.40) TNK2CYP3A4IGF1RADORA3
SCHEMBL5081269 0.88 CYP3A4 (0.39) TNK2SYKALDH1A1KDM4EHPGD
SCHEMBL5080265 0.86 RAB9A (0.35) TNK2ALDH1A1KDM4ESMN1; SMN2HPGD
SCHEMBL5082839 0.83 TNK2 (0.41) TNK2ALDH1A1KDM4ELMNAHPGD
SCHEMBL5083969 0.79 IGF1R (0.46) TNK2CYP3A4IGF1R
SCHEMBL5078929 0.78 IGF1R (0.35) TNK2SYKTGFBR1CYP3A4PDE10A
SCHEMBL5081943 0.77 IGF1R (0.35) SYKKDM4ECYP3A4IGF1R
SCHEMBL5086104 0.76 IGF1R (0.48) TNK2SYKCYP3A4IGF1R
SCHEMBL5313007 0.76 IGF1R (0.45) TNK2CYP3A4IGF1R
SCHEMBL5082157 0.75 IGF1R (0.38) TNK2CYP3A4IGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1979002-A2 COMBINATION OF IGFR INHIBITOR AND ANTI-CANCER AGENT OSI Pharmaceuticals, Inc. (US) 2008-10-15 EP claimed
WO-2007075554-A2 COMBINATION OF IGFR INHIBITOR AND ANTI-CANCER AGENT OSI PHARMACEUTICALS, INC. (US) 2007-07-05 WO claimed
WO-2008076143-A1 COMBINATION OF IGFR INHIBITOR AND ANTI-CANCER AGENT OSI PHARMACEUTICALS, INC. (US) 2008-06-26 WO disclosed